Login / Signup
Reply to Epling and Powers, "Cefiderocol and the Need for Higher-Quality Evidence: Methods Matter for Patients".
Marco Falcone
Giusy Tiseo
Published in:
Antimicrobial agents and chemotherapy (2022)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
gram negative
quality improvement
patient reported